January 30, 2020 | News
FabRx is proud to announce that their Senior Formulation Scientist, Patricija Januskaite, will be presenting at the SMi’s 4th annual conference on 3D Bioprinting in London on the 18th of February:
Our FabRx representative will be talking about numerous 3D printing technologies that FabRx is currently working on and the company’s novel 3D printer, M3dimaker, alongside the clinical need for personalised medicines in the pharmaceutical industry.
As part of the conference’s panel discussion, Patricija will be joined by GlaxoSmithKline, Merck and Novartis to discuss the applications of bioprinting in drug screening and optimised delivery for patients.
Copyright © 2018 FabRx Ltd